Summary by Futu AI
Kangfang Biotechnology (Cayman) Limited completed the distribution of new shares under general mandate on 28 March 2024 and filed the next day's disclosure report with the Hong Kong Stock Exchange Limited on the same day. The company disclosed details of the distribution of new shares in its announcements dated March 21, 2024 and March 28, 2024. The number of shares issued was 24,800,000 shares, representing 2.95% of the shares issued prior to issue. The issue price was HKD 47.65 per share, up 2.14% from the previous business day's closing price of HKD 46.65. After the issuance, the issued share capital of the company increased from 841,057,176 shares to 865,857,176 shares. The Company confirms that all payments have been received and that all the conditions required by the Listing Rules have been met.